-
Product Insights
NewLoch Kemp
Loch Kemp is a Hydro project located in United Kingdom. The project is owned and being developed by Statera Energy Ltd. The project is at the permitting stage. Empower your strategies with our Loch Kemp report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed...
-
Product Insights
NewChickerell Solar PV Park
Chickerell Solar PV Park is a solar PV project located in England, United Kingdom. The project is owned and being developed by Statera Energy Ltd. The project is expected to come online in 2027. Empower your strategies with our Chickerell Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AR-601 in Food Allergy
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.AR-601 in Food AllergyDrug Details:AR-601 is under development for the treatment of multi-nut allergy.Report CoverageThe data...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IQP-0528 in Human Immunodeficiency Virus (HIV) Infections (AIDS)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.IQP-0528 in Human Immunodeficiency Virus (HIV) Infections (AIDS)Drug Details: IQP-0528 is under development for the prevention...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TILT-123 in Head And Neck Cancer Squamous Cell Carcinoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.TILT-123 in Head And Neck Cancer Squamous Cell Carcinoma Drug Details:TILT-123 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Entolimod in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Entolimod in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Drug Details:Entolimod (CBLB-502) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BT-8009 in Peritoneal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BT-8009 in Peritoneal Cancer Drug Details: BT-8009 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Metenkefalin in Kaposi Sarcoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Metenkefalin in Kaposi SarcomaDrug Details: IRT-101 (methionine-enkephalin) is under development for the treatment of pancreatic cancer,...
-
Product Insights
Statera Energy – Chickerell Solar Power 300 MW and Battery Storage Plant – Dorset
Equip yourself with the essential tools needed to make informed and profitable decisions with our Statera Energy - Chickerell Solar Power 300 MW and Battery Storage Plant - Dorset report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Product Insights
Statera Energy – Loch Kemp Hydro Pumped Storage Plant 600 MW – Highland
Equip yourself with the essential tools needed to make informed and profitable decisions with our Statera Energy - Loch Kemp Hydro Pumped Storage Plant 600 MW - Highland report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...